Symptomatic Circumscribed Choroidal Hemangioma Undergoing PDT: VA Outcomes
| Autor: | James Fabian, Shao Huang, Timothy G. Murray, Wei Shi |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
Adult
medicine.medical_specialty Visual acuity genetic structures medicine.medical_treatment Snellen VA Visual Acuity Photodynamic therapy Triamcinolone Acetonide Injections Pharmacotherapy Ophthalmology medicine Humans Initial treatment Circumscribed choroidal hemangioma Glucocorticoids Retrospective Studies business.industry Choroid Neoplasms Retrospective cohort study Middle Aged Acetonide eye diseases Vitreous Body Treatment Outcome Photochemotherapy Drug Therapy Combination sense organs medicine.symptom Hemangioma business Follow-Up Studies Optometry |
| Zdroj: | Optometry and Vision Science. 86:286-289 |
| ISSN: | 1040-5488 |
| DOI: | 10.1097/opx.0b013e318196a724 |
| Popis: | Purpose. To report visual acuity (VA) outcomes in eyes undergoing photodynamic therapy (PDT), with or without concurrent intravitreal Triamcinolone acetonide (IVTA), for symptomatic circumscribed choroidal hemangioma. Methods. We retrospectively reviewed clinical records of 16 patient treated from January 2001 to May 2006. Post-treatment Snellen VA was compared with pretreatment measurements. Results. Ten eyes underwent only PDT therapy, in which VA in three eyes improved by more than two lines and seven eyes remained stable. Four eyes were treated with combined PDT and IVTA. VA in two of those eyes improved more than 2 lines, one eye remained stable, and one eye worsened at most recent follow-up. Another two eyes failed initial treatment elsewhere and were not included in the final analysis. Conclusion. VA outcome is generally good in patients treated with PDT alone. This study was limited by a small sample size of PDT/IVTA treatment group, therefore, we could not compare outcomes to the PDT alone treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|